This two-day virtual conference focuses on translational aspects of addiction research among chemists, biologists, and behavioral scientists. The diversity of participants and attendees at this meeting (undergraduate students to senior faculty, chemists to psychiatrists) provides a unique venue for networking among different disciplines and in so doing promotes new and innovative approaches to medications development in addictions biology. The meeting provides a stimulating environment for young scientists who are strongly encouraged to present their work and interact with senior scientists. The BBC meeting has served as a “launch pad” for many young, innovative investigators to join the ever-growing world of SUD research.
![]() Christian Heidbreder, PhDReckitt Benckiser Pharmaceuticals Topic: Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders |
![]() R Adron Harris, PhDUniversity of Texas at Austin Topic: Small molecule seeks protein partners for meaningful relationship |
![]() F Ivy Carroll, PhDResearch Triangle Institute Topic: Development of selective kappa opioid receptor antagonists |
![]() |
Amy H Newman, PhDNational Institute on Drug Abuse |
Evolution of D3 receptor antagonists and partial agonists |
![]() |
Bruce Jenkins, PhDHarvard Medical School/Massachusetts General Hospital |
phMRI of D3 receptors in rodents and primates |
![]() |
Robert R Luedtke, PhDUniversity of North Texas Health Science Center |
Functional selectivity of D3 dopamine receptor-selective ligands |
![]() |
Michael A Nader, PhDWake Forest University |
Interactions of cocaine history with the behavioral effects of D3 compounds in nonhuman primates |